| 前收市價 | 5.62 |
| 開市 | 5.62 |
| 買盤 | 0.95 |
| 賣出價 | 3.60 |
| 拍板 | 14.00 |
| 到期日 | 2024-08-16 |
| 今日波幅 | 5.62 - 5.62 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 102 |
ZacksGeron (GERN) Wins FDA Approval for Blood Cancer Drug, Stock Up
Geron's (GERN) shares rise on approval of its first drug. The FDA approves imetelstat for the treatment of adult patients with lower-risk MDS with transfusion-dependent anemia.
ZacksChromaDex (CDXC) Up as Ataxia Candidate Gets Orphan Drug Tag
ChromaDex (CDXC) rises 12% as the FDA grants the Orphan Drug Designation and the Rare Pediatric Disease Designation to its investigational candidate, NRC, to treat ataxia telangiectasia.
ZacksModerna (MRNA) Submits Updated COVID-19 Jab to FDA for Review
Moderna (MRNA) completes regulatory filing of its Spikevax 2024-2025 formula, targeting the COVID-19 variant JN.1 to the FDA for the upcoming vaccination season.
